جست‌وجوی استاد و پژوهشگر

KEMAL OZAN LÜLEمشاهده پروفایل

استادیار

• Internal Medicine
• Endocrinology
• Gastroenterology
• +۶ مورد دیگر

KEMAL OZAN LÜLE is an Assistant Professor at Gaziantep University, Faculty of Medicine, Department of Internal Medicine , with an email contact at ozan@gantep.edu.tr . He holds an ORCID identifier and is registered in the YÖK Academic Information System. Education: Medical License from Dokuz Eylül University (2009–2016), Medical Specialization from Gaziantep University (2017–2021). Professional Experience: Specialist at Gaziantep Abdulkadir Yuksel State Hospital (2021–2024), General Practitioner at Arapgir Ali Özge State Hospital (2016–2017). Administrative Roles: Member of Measurement and Evaluation Board (2024), Internal Medicine Internship Education Coordinator (2024), English Medicine Assistant Coordinator (2024). His research focuses on Internal Medicine , with emphasis on Diabetes , Fatty Liver Disease , Neurocognitive Effects of diabetes treatments, Cancer Development linked to food preparation, Irritable Bowel Syndrome , and Adrenal Incidentaloma . Book Chapters: Development and Natural Course of Diabetic Fatty Liver Disease (2025), Effects of Pharmacological Agents on Neurological Functions (2023), Food Preparation Methods and Cancer (2023). He has co-authored multiple proceedings papers on topics including Temporal Arthritis , Lymphoma , Behçet’s Disease , and Fahr Syndrome , presented at national and international conferences.

• Cardiovascular Research
• Hypertension
• Pharmacology
• +۵ مورد دیگر

Nancy J. Brown, M.D., is the Jean and David W. Wallace Dean of the Yale School of Medicine and holds the C.N.H. Long Professorship in Internal Medicine. Previously, she served as Chair of Vanderbilt Department of Medicine and Physician-in-Chief of Vanderbilt University Medical Center (2010–2020). Her academic career spans over three decades, with leadership roles in clinical care, research, and medical education. Education: MD, Harvard University (1986) AB in Molecular Biophysics and Biochemistry, Yale College (1981) Internship and Residency in Medicine, Vanderbilt University (1989) Fellowship in Clinical Pharmacology, Vanderbilt University (1991) Chief Resident, Vanderbilt University (1992) Research Interests: Dr. Brown’s work focuses on the renin-angiotensin-aldosterone system’s role in cardiovascular disease, hypertension, and thrombosis. Her lab has elucidated mechanisms linking aldosterone, bradykinin, and ACE inhibitors to inflammation, fibrosis, and cardiovascular risk. Current studies explore neprilysin inhibitors in heart failure and incretin-based therapies’ cardiovascular effects. Key Contributions: Identified genetic variants and African ancestry as risk factors for ACE inhibitor-associated angioedema Developed Vanderbilt’s Master of Science in Clinical Investigation program (2000) Advocated for physician-scientist development through leadership roles in NIH councils and professional organizations Recognition: Recipient of the Harriet Dustan Award, August M. Watanabe Prize, and Robert H. Williams Distinguished Chair of Medicine. Elected to the National Academy of Medicine and American Academy of Arts & Sciences. Labs/Teams: Leads the Yale School of Medicine’s cardiovascular research initiatives, focusing on translational studies of RAAS pathways and drug mechanisms.

Angelica Lindén Hirschbergمشاهده پروفایل

استاد

• Reproductive Medicine
• Endocrinology
• Polycystic Ovary Syndrome (PCOS)
• +۵ مورد دیگر

Angelica Lindén Hirschberg is a Professor of Obstetrics and Gynecology (specializing in reproductive medicine) at Karolinska Institutet and a Senior Consultant in gynecological endocrinology at Karolinska University Hospital. She holds dual roles in academic leadership and clinical practice, focusing on disorders of reproductive function, endocrine-metabolic dysfunction, and hormonal conditions in women. Her affiliations include the Department of Women’s and Children’s Health, Reproductive Endocrinology and Metabolism Research Group, and the Division for Neonatology, Obstetrics, Gynaecology, and Reproductive Health. Education and Career: MD (Karolinska Institutet, 1984) PhD (Karolinska Institutet, 1989) Professor in Obstetrics and Gynecology (2007) Board member of international societies (ISGE, EMAS) Research Focus: Her translational research spans PCOS, obesity-related reproductive dysfunction, premature ovarian insufficiency, and disorders of sex development. Projects include hormonal impacts on athletic performance, immune therapy for ovarian dysfunction, and endometrial cell biology. Collaborations involve national/international networks and clinical trials (e.g., PROBES trial). Publications: Recent work emphasizes PCOS pathophysiology, menopausal health, and hormonal interventions in athletes. Key trends include single-cell profiling of endometrium, immunomodulatory therapies for POI, and non-hormonal treatments for vasomotor symptoms. Awards: King’s Seraphim Medal (2018) 2016 Grand Prize in Sport Science Appointed Royal Gynecologist (2009) Teaching and Mentorship: Coordinates courses on reproductive endocrinology, supervises PhD students (e.g., Esin Ylmaz), and chairs the PhD Study Director at her department. Authored over 25 book chapters on women’s health and sports medicine. Grants and Labs: Secured Swedish Research Council funding for POI trials. Her lab integrates experimental (Bioclinicum) and clinical (Women’s Health Research Unit) research.

• Artificial intelligence
• Biomedical signal processing
• Human movement analysis
• +۱۲ مورد دیگر

Marco Ghislieri is an Assistant Professor at the Department of Electronics and Telecommunications (DET) of Politecnico di Torino, Italy. He is a member of the Interdepartmental Center PolitoBIOMed Lab and teaches in the Biomedical Engineering program, including courses like Neuroengineering and Design of Programmable Biomedical Devices . His research spans Artificial Intelligence, Biomedical Signal Processing, Neuroscience, and Rehabilitation Engineering . PhD in Bioengineering and Medical-Surgical Sciences (2017-2021) at Politecnico di Torino Thesis: Muscle Synergy Assessment during Cyclic and Non-Cyclic Movements His research focuses on muscle synergy analysis in Parkinson’s Disease (PD) patients post- Deep Brain Stimulation (DBS) , AI-driven gait analysis for fall prevention, and wearable sensor applications for stress-cognitive decline monitoring. He leads the S-CoDe and OMNIA-PARK projects, and contributes to PRIN as a team member. Recent publications highlight advancements in machine learning for intraoperative DBS targeting , statistical gait analysis , and neurorehabilitation tools . He serves as Associate Editor for Scientific Reports and Applied Bionics and Biomechanics , and Guest Editor for Frontiers in Neural Circuits . Awards include the Carlo J. De Luca Award (2022) , GNB Doctoral Award (2022) , and the Best Poster Award at M. Grattarola Summer School (2022) . He supervises Fabrizio Sciscenti (PhD candidate) and collaborates on neuroengineering and biomedical device design courses. His work addresses Goal 3 (Good Health) and Goal 4 (Quality Education) of the UN SDGs.

• Cancer
• Liver Pathology
• Tumor Suppression
• +۶ مورد دیگر

Professor Alain de Bruin (born 1968) is a distinguished academic at Utrecht University, serving as Professor in the Department of Biomolecular Health Sciences within the Faculty of Veterinary Medicine. Since January 1, 2020, he has been Head of the Department of Biomolecular Health Sciences. His academic journey began with veterinary medicine studies at the University of Hannover in Germany, followed by a PhD from the University of Bern in Switzerland in 1999. After specializing in veterinary pathology and completing a postdoctoral position at Ohio State University, he was appointed professor of pathobiology at Utrecht University in 2005. In 2010, he founded the Netherlands Molecular Pathology Center (UU/UMCG) and became an honorary professor of molecular pathology at the University of Groningen in 2014. Professor de Bruin's research primarily focuses on cancer biology, liver pathology, tumor suppression mechanisms, and aging processes. His expertise includes in vivo modeling, cell cycle analysis, generating transgenic mouse models, pathological analysis of animal disease models, and single-cell transcriptomics. His work centers on proteins that regulate cell proliferation, particularly E2F transcription factors, which he has discovered play critical roles in inhibiting cancer cell growth. His research themes span Life Sciences, Regenerative Medicine, and the Utrecht Platform for Organoid Technology. Analysis of his recent publications reveals a consistent research trajectory centered on cell cycle regulation, particularly the atypical E2F transcription factors (E2F7 and E2F8), and their roles in cancer development, polyploidization, and liver disease. His work demonstrates how these factors influence tumor suppression, angiogenesis, and cellular responses to DNA damage. The publications span multiple disciplines including cancer biology, molecular oncology, hepatology, and regenerative medicine, with applications in both human and veterinary medicine. Professor de Bruin has held significant leadership positions, including chairing the research council (2017-2019) and coordinating the 'Regenerative Medicine, Stem Cells, and Cancer' research program (2013-2019). He serves on the editorial board of 'Frontiers in Cell and Developmental Biology' and participates in review committees for NWO-Rubicon/Veni, the research alliance UTwente/UU/UMCU, and the Comprehensive Cancer Center at Ohio State University. His laboratory work has made significant contributions to understanding how E2F transcription factors regulate cell proliferation, with implications for developing novel cancer therapy strategies. His research on polyploidization mechanisms has provided insights into liver regeneration and tumor development, while his work on senescence has implications for aging-related diseases.

• Endocrinology
• Adrenal Gland Research
• Immunology
• +۶ مورد دیگر

Professor Stefan R. Bornstein serves at the Technical University of Dresden's Carl Gustav Carus University Hospital within Medical Clinic and Polyclinic III. He leads multiple German Research Foundation (DFG)-funded projects focusing on adrenal function, metabolic diseases, and immunological mechanisms, with particular expertise in sepsis-related adrenal dysfunction and the hypothalamic-pituitary-adrenal axis. Dr. Bornstein's research centers on endocrine-immunological interactions, examining how the adrenal gland functions as a central regulatory organ in health and disease. His work spans molecular mechanisms of intra-adrenal regulation, immune responses in sepsis, and metabolic drivers of infection susceptibility, with significant translational potential for treating adrenal insufficiency and obesity-related conditions. As speaker of International Research Training Groups RTG 2251 and RTG 3019, he directs collaborative research on immunological strategies for metabolic diseases and infection susceptibility. His Transregio project TRR 205 investigates the adrenal gland's role as a central relay in physiological regulation, while his sub-project management in Transregio initiatives focuses on adrenal stem cells and biological replacement therapies. Dr. Bornstein has secured substantial research funding through multiple DFG projects including investigations into regulated cell death in adrenal inflammation, xenogeneic cell transplantation for adrenal insufficiency, and the microenvironment of the adrenal gland in health and disease. His earlier work established important connections between adipose tissue, aldosterone regulation, and hypertension. His laboratory employs advanced model systems to study adrenal physiology across molecular, cellular, and systemic levels, with particular focus on therapeutic interventions for sepsis-induced adrenal dysfunction and stem cell-based approaches for endocrine disorders.

• Adrenal Development
• Reproductive Development
• Transcriptomics
• +۱۰ مورد دیگر

Prof John Achermann is a Clinical Professor of Paediatric Endocrinology at the Genetics & Genomic Medicine Department , University College London (UCL), with an active role at the UCL GOS Institute of Child Health since 2023. His career spans clinical and research expertise in adrenal and sex development , genetic mechanisms of disease , and nuclear receptor biology , highlighted by over 200 publications and an h-index of 67. Education: Bachelor of Arts (Honours), University of Cambridge (1988) Bachelor of Medicine, University of Cambridge (1990) Master of Arts, University of Cambridge (1992) Doctor of Medicine (MD), University of Cambridge (1997) Doctor of Philosophy (PhD), University of Cambridge (2011) His research focuses on molecular genetics of adrenal and reproductive development , integrating transcriptomics and genomic medicine to understand disorders like Turner syndrome, Disorders of Sex Development (DSD), and adrenal insufficiency. Recent work includes single-cell analyses of fetal gonads , exome sequencing for DSD/POI , and NR5A1/SRY regulatory mechanisms . Key awards include the 2025 ESPE Research Award , 2023 Henning Andersen Prize , and 2016 Clinical Endocrinology Trust Lecturer Medal . Scientific Awards: ESPE Research Award (2025) Henning Andersen Prize (2023, 2007) Clinical Endocrinology Trust Lecturer Medal (2016) SPARKS/RCPCH Young Investigator (2007) ESPE Young Investigator (2002) Noble Prize for MD Thesis (1998) As Head of the Molecular Basis of Rare Disease Section and Deputy Head of Genetics & Genomic Medicine at UCL GOS Institute of Child Health, he bridges clinical practice with translational research. He contributes to undergraduate and postgraduate medical education , supervises MSc projects, and serves on the ESPE Local Organising Committee for 2024. His work aligns with UN Sustainable Development Goals for Good Health & Well-Being and Gender Equality .

• Clinical Biochemistry
• Infectious Diseases
• Physiology
• +۴ مورد دیگر

Lennart Jan Friis-Hansen is a visiting researcher affiliated with the Department of Clinical Research at the University of Southern Denmark (SDU) and the Research Unit of Clinical Biochemistry at Odense University Hospital (OUH) . His work spans clinical biochemistry, infectious diseases, and endocrinology, with a focus on biomarker analysis, diagnostic testing, and physiological responses to diseases. Active in Department of Clinical Research at SDU and OUH Research interests include COVID-19 pathogenesis , steroid hormone dynamics , bone density in athletes , and Vitamin K in respiratory disease Recent publications highlight his contributions to ACE2/TMPRSS2 receptor studies in kidney tissue , diagnostic accuracy of PCR assays , and hormonal impacts on athlete health . His work also addresses vitamin deficiencies in chronic disease and cortisol immunoassay standardization . Press contributions in 2024–2025 emphasize gaps in post-vaccine injury treatment and adverse effects of effective therapies . Affiliated with research units at SDU and OUH, he collaborates on interdisciplinary studies in clinical biochemistry and physiology.

• Progranulin research
• Neuroprotection
• Tissue repair
• +۴ مورد دیگر

Andrew Bateman, PhD is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, where he leads research in the Metabolic Disorders and Complications Program within the Centre for Translational Biology. He holds a professorship in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University, with specific affiliation to the Division of Endocrinology at the McGill University Health Centre. Dr. Bateman's research primarily focuses on progranulin, a protein that plays crucial roles in cell communication, neuroprotection, tissue repair, and cancer progression. His work has demonstrated that progranulin instructs nearby cells to divide and move, inhibits cell death caused by challenges such as starvation or chemotherapeutic drugs, and is essential for keeping nerve cells alive. Notably, his research has shown that losing half of the brain's progranulin levels through mutation causes frontotemporal dementia, a devastating degenerative brain disease. His laboratory also investigates how progranulin is overexpressed in many cancers, rendering cancer cells more aggressive, and how blocking progranulin may serve as a route to cancer therapy. Additionally, his work explores progranulin's role in reducing inflammation and promoting wound repair, including angiogenesis, which has potential applications for people suffering from chronic wounds. Analysis of Dr. Bateman's publication record reveals a consistent focus on progranulin across multiple disciplines including neuroscience, molecular biology, oncology, and vascular biology. His research spans from fundamental protein structure and evolution to clinical applications in neurodegenerative diseases and cancer. A notable trend in his work is the exploration of progranulin's dual role in both neuroprotection and cancer progression, highlighting the complex nature of this regulatory protein. His research has evolved from early work on corticostatic peptides and the immune-hypothalamic-pituitary-adrenal axis to his current specialized focus on progranulin's multifaceted biological functions. Dr. Bateman has made significant contributions to understanding the role of progranulin in various physiological and pathological processes. His work has implications for developing therapeutic approaches for neurodegenerative diseases, cancer treatment, and wound healing. He has established himself as a leading researcher in the field of progranulin biology, with numerous publications in high-impact journals spanning several decades of research.

Elizabeth Videlockمشاهده پروفایل

استادیار

• Gut-brain axis
• Parkinson's disease
• Irritable bowel syndrome
• +۵ مورد دیگر

Elizabeth Videlock, M.D., Ph.D. is an Assistant Professor of Medicine at the David Geffen School of Medicine , University of California, Los Angeles (UCLA) . Her laboratory is housed within the UCLA Center for Inflammatory Bowel Diseases and she leads the Videlock Laboratory . She is a physician-scientist with dual training in internal medicine and gastroenterology, and a Ph.D. in translational research focused on the gut-brain axis. Education and Training: B.S., Chemistry – Yale University M.D. – David Geffen School of Medicine at UCLA Internal Medicine Residency – Beth Israel Deaconess Medical Center, Boston Gastroenterology Fellowship – UCLA STAR Program Ph.D. – UCLA, under mentorship of Dr. Charalabos Pothoulakis and Dr. Lin Chang Research Focus: Dr. Videlock’s research centers on the gut-brain axis , with a particular emphasis on Parkinson’s disease and irritable bowel syndrome (IBS) . Her lab uses clinical samples, animal models, and cell-based systems to investigate how gastrointestinal dysfunction contributes to neurological disease. Key areas include mitochondrial dysfunction in the gut epithelium, alpha-synuclein pathology, and the role of genes like PINK1 and PRKN in intestinal health. Scientific Awards and Honors: NIH-NIDDK K08 Grant Award (2024) UCLA CTSI KL2 Translational Science Award (2023) Chan Zuckerberg Initiative Neurodegeneration Challenge Grant American Gastroenterological Association (AGA) FORWARD Scholar Funding and Grants: NIH-NIDDK K08: “Intestinal Mitochondrial Dysfunction and the Gut-Brain-Immune Axis in Models of Parkinson’s Disease” UCLA CTSI KL2: “Parkinson's Disease May Begin in the Gastrointestinal Tract” Chan Zuckerberg Initiative: “The Role of Pink1/Parkin in the Intestinal Epithelium” CURE Pilot and Feasibility Grant UCLA Claude Pepper Rapid Pilot Award Laboratory and Affiliations: Dr. Videlock leads the Videlock Laboratory within the UCLA Center for Inflammatory Bowel Diseases . She is also affiliated with the UCLA G. Oppenheimer Center for Neurobiology of Stress and Resilience and the UCLA Vatche and Tamar Manoukian Division of Digestive Diseases .

• Bioinformatics
• Genomics
• Cardiovascular Disease Research
• +۴ مورد دیگر

Dr. Claudia Cabrera is a Senior Lecturer in Bioinformatics at Queen Mary University of London, affiliated with the William Harvey Research Institute within the Faculty of Medicine and Dentistry. Her primary department is Clinical Pharmacology and Precision Medicine. Her research focuses on developing bioinformatics tools for understanding complex traits and diseases, particularly in genetical genomics of hypertension, cardiovascular diseases, trauma response, and pediatric endocrinology. She leads the development of software like genomicper , which uses circular genomic permutation to analyze GWAS data, enhancing pathway association significance while accounting for genomic structure. Her work integrates high-throughput data analysis (e.g., whole-genome sequencing, RNA-Seq) and genomic pathway testing frameworks. Key projects include studying somatic mutations in aldosterone-producing adenomas and genetic variants linked to puberty timing. She collaborates with the NIHR Barts Cardiovascular Biomedical Research Centre and has published extensively on hypertension genetics, genomic permutation methods, and precision medicine applications. Dr. Cabrera’s research emphasizes translational medicine, bridging computational biology with clinical outcomes in cardiovascular and endocrine disorders. Her lab’s innovations in genomic analysis tools are widely applied in understanding disease mechanisms and drug target discovery. She also investigates trauma-induced inflammation and genomic drivers of blood pressure regulation through large-scale genetic studies.

Breanna N. Harrisمشاهده پروفایل

استادیار

• Stress Physiology
• Hypothalamic-Pituitary-Adrenal (HPA) Axis
• Behavioral Endocrinology
• +۳ مورد دیگر

Dr. Breanna N. Harris is an Assistant Professor in the Department of Biological Sciences at Texas Tech University, where she leads an integrative research program focused on stress physiology and its impacts on behavior, reproduction, and health. She holds a Ph.D. in Evolution, Ecology, and Organismal Biology from the University of California, Riverside (2007-2012) and a B.S. in Marine Biology from Ohio University (2001-2005). Her work bridges comparative biology, behavioral endocrinology, and human health applications, with notable contributions to understanding the hypothalamic-pituitary-adrenal (HPA) axis across species. Education: Ph.D., Evolution, Ecology, and Organismal Biology, University of California, Riverside (2007-2012) B.S., Marine Biology, Ohio University (2001-2005) Research Interests: Dr. Harris's research centers on how stressors influence organismal function and life-history trade-offs. She employs a comparative approach, studying species ranging from crabs and sharks to mice and humans, to investigate the behavioral and physiological consequences of stress-response plasticity. Key themes include the role of the HPA axis in health and disease, the impact of sensory perception and genotype on stress responses, and the translation of stress into functional outcomes like cognition and reproduction. Scientific Awards: Inducted into the TTU Teaching Academy (2019) Outreach and Education: Dr. Harris is deeply committed to science communication and education. She co-curated the NSF-funded museum exhibit Why Frogs Don’t Get Fat: Predators, Fear, and Feeding in the Wild at the Museum of Texas Tech and developed educational resources tied to the film To Dust . Her lab actively involves undergraduate students in research, fostering the next generation of scientists. Teaching: Biology 4301-D79: Human Reproduction and Sexual Behavior (online) Biology 4301-079: Peer Mentoring in Human Physiology Zoology 2404: Anatomy and Physiology II Biology 4301-079: Brain, Behavior and Hormones

• Pharmacology
• Toxicology
• Pharmaceutical Sciences
• +۵ مورد دیگر

Liesbeth Ruijgrok serves as a Researcher within the Pharmacy department at Erasmus University Medical Center (Erasmus MC) in Rotterdam, Netherlands. Her academic work bridges pharmaceutical science with clinical applications, focusing on optimizing drug therapies for complex medical conditions through rigorous translational research. Her primary research spans Pharmacology, Toxicology, and Pharmaceutical Sciences with specialized expertise in Adrenal Insufficiency management, Preeclampsia pathophysiology, Drug-Drug Interactions, and advanced Drug Delivery Systems. She pioneers innovative approaches including pharmaceutical 3D printing for personalized hydrocortisone formulations, functional respiratory imaging for aerosol deposition analysis in pediatric asthma, and mechanistic studies of statins in hypertensive pregnancy disorders. Her work consistently addresses critical therapeutic challenges in pharmacokinetics and pharmacodynamics. Analysis of her 2024 publications reveals a strong trend toward solving real-world pharmacotherapy problems through technological innovation and mechanistic understanding. Key themes include cost-effective manufacturing of personalized medicines, precision drug delivery for respiratory diseases, and repurposing existing drugs for novel indications like preeclampsia. Her collaborative studies frequently integrate clinical data with pharmaceutical technology to enhance therapeutic outcomes. No scientific awards were documented in the available profile information. No details regarding student mentorship, research grant funding, or laboratory infrastructure were provided in the source materials. Her research appears to be conducted through multidisciplinary collaborations within Erasmus MC's clinical departments rather than a dedicated independent laboratory.

• Ion Transport Physiology
• Molecular Cell Biology
• Biophysics
• +۳ مورد دیگر

Thomas J. Jentsch is a leading Professor at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, with secondary affiliation to the Max Delbrück Center (MDC) . He holds dual doctorates in Medicine and Physics from Freie Universität Berlin and has pioneered research in ion transport physiology since co-founding the Center for Molecular Neurobiology Hamburg in 1988. Head of Jentsch Group at FMP since 2006 World leader in chloride channel research His research bridges molecular physiology and human genetics , focusing on: CLC family chloride channels/transporters VRAC/LRRC8 volume-regulated channels ASOR/TMEM206 acid-activated channels Pathologies: neurodegeneration, deafness, osteopetrosis, hypertension Recent work includes breakthroughs in VRAC channel structure (2023) and CLCN7 channelopathies (2024). His lab employs genetically modified mouse models and human mutation analysis to uncover disease mechanisms.

Andrew Titmanمشاهده پروفایل

استاد

• Survival Analysis
• Multi-State Modeling
• Medical Statistics
• +۳ مورد دیگر

Andrew Titman is a Professor in the School of Mathematical Sciences at Lancaster University . His research focuses on survival analysis and multi-state modeling with applications in medical statistics and quantitative methodology. Primary Affiliation: School of Mathematical Sciences, Lancaster University Contact: a.titman@lancaster.ac.uk Research Interests include: Development of non-Markov multi-state models for complex survival data Latent variable modeling for health-related quality of life questionnaires Methodology for informative observation times in clinical trials Health economic decision modeling applications Survival analysis with misclassification and time non-homogeneity Recent Publications demonstrate expertise in: Bayesian state-space models for sports analytics Multi-state model diagnostics and goodness-of-fit testing Medical applications in endocrinology and hematology Simulation methodology with input uncertainty quantification Scientific Contributions include: Development of R packages: nhm, CIFresolve, miscIC Creation of the MarkovTest GitHub repository for multi-state model validation Methodological frameworks for non-homogeneous Markov models